ERBiosys is a Lithuania-based bioinformatics company that focuses on precision oncology research and development of a genetic breast cancer test to advise women on an optimal treatment. To identify patterns leading to precise treatment recommendations we use our proprietary AI technology.
w

Bioinformatics and Precision Medicine are the
keys to solving CANCER

Scroll Down

We are aiming to create an affordable genetic test to harness the power of precision oncology

01

Pr

Precision Oncology

Personalized therapy selection based on tumor genetics

02

B

Bioinformatics

Computational analysis of large and complex biological data sets

03

M

Machine Learning

Usage of data sets and AI models to identify targeted treatments

04

On

Molecular Oncology

Identification of cancer signaling pathways and solving drug resistance

05

Sw

Software Engineering

Full-stack bioinformatics software development

06

Tx

Onco-Toxicology

Analysis of cancer drug toxicity based on unique genetics of patient

07

Mx

Multiomics

Analysis of data from genomics, epigenomics, proteomics and transcriptomics

08

N

Neuro-Oncology

RnD of neurological methods to suppress cancer metastasis

09

E

Cancer Education

Content creation about benefits of precision oncology and healthy lifestyle

10

Am

Alternative Medicine

Analysis of evidence based recoveries studies using alternative treatment methods

What makes ERBiosys unique?

  • identification of cancer signaling pathways based on multiomic molecular information,
  • evaluation of drug toxicity for a particular person,
  • analysis of mechanisms of drug resistance,
  • providing recommendations by referencing NCCN and ESMO guidelines, clinical trials, PubMed and other academical research publications,
  • affordable test price.